Stem cell therapies closer to clinic

March 8, 2013

group of researchers in the United States and South Korea has announced a leap towards safe, clinically useful patient-specific stem cells. If the researchers are right, clinical trials on the induced pluripotent stem (iPS) cells, which can turn into virtually any cell type and potentially be used to treat disorders ranging from spinal cord injury to diabetes, could start within two years. (The Guardian – Nigeria)